ClinicalTrials.Veeva

Menu

Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

C

China Medical University

Status

Unknown

Conditions

Mycobacterium Infection

Study type

Observational

Funder types

Other

Identifiers

NCT01628744
DMR-99-IRB-075-1

Details and patient eligibility

About

In adult, the prevalence of mycobacterial infections is increased with age is largely unknown. IFN-gamma-IL-12/23 axis or NF-kappaB pathways might also plays crucial roles in adult against mycobacteria. Based on this hypothesis, the investigators had applied a functional assay to these pathways in patients with mycobacterial infection.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with mycobacterial infection

Exclusion criteria

  • Malignancy
  • Severe autoimmune
  • HIV infection

Trial design

100 participants in 1 patient group

Patients with mycobacterial infection

Trial contacts and locations

1

Loading...

Central trial contact

Cheng-?Lung KU, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems